002898 *ST赛隆药业
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.208-6.4041.795-6.846-4.057
总资产报酬率 ROA (%)-0.129-4.0871.147-4.312-2.751
投入资产回报率 ROIC (%)-0.145-4.6611.351-5.131-3.171

边际利润分析
销售毛利率 (%)49.58938.25346.18653.46666.220
营业利润率 (%)-1.984-13.4387.265-10.897-5.498
息税前利润/营业总收入 (%)1.176-10.8059.361-8.621-3.403
净利润/营业总收入 (%)-1.920-12.5763.069-14.123-9.447

收益指标分析
经营活动净收益/利润总额(%)81.46047.142-11.329123.789182.717
价值变动净收益/利润总额(%)0.734-0.20335.401-57.609-110.568
营业外收支净额/利润总额(%)1.122-1.425-0.9402.9681.336

偿债能力分析
流动比率 (X)0.9750.9801.1290.8581.085
速动比率 (X)0.6290.6110.7380.6420.886
资产负债率 (%)38.15438.22534.15437.93236.150
带息债务/全部投入资本 (%)27.75326.77120.60323.48823.661
股东权益/带息债务 (%)250.251260.955367.609318.544317.209
股东权益/负债合计 (%)162.095161.607192.790163.631176.628
利息保障倍数 (X)0.370-4.4224.326-3.304-1.568

营运能力分析
应收账款周转天数 (天)126.00465.17851.81281.61976.328
存货周转天数 (天)302.800202.345164.582171.230249.558